Capital raised by Jasper Therapeutics
1 Form D filing · first filed Jul 2026 · Redwood City, CA
Director
Listed on Jasper Therapeutics's Form D filings
Matthew Ros is on file as Director at Jasper Therapeutics in Redwood City, CA. Jasper Therapeutics has 1 Form D filing on record, $132.0M raised in total.
An investigational aglycosylated monoclonal antibody targeting KIT (CD117) that blocks stem cell factor signaling and depletes mast cells and hematopoietic stem cells via apoptosis, in development for chronic urticaria and progressing toward a pre-BLA meeting in severe combined immunodeficiency (SCID).
